Hyloris Pharmaceuticals SA

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

32.23%

Market Cap

126.00 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.23 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE4.61 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 12:16:39 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW4.614.43
PREV. DAY'S PRICE4.5 (07/21)
CHANGE DAY BEFORE
+0.11
2.44 %
52 WEEK HIGH / LOW8.1 (01/23)4.2 (07/08)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.55-0.23-0.23-0.36-0.20
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
9.145.707.23--
PRICE - SALES RATIO
171.0621.6526.57--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A2P7Y0
ISIN
BE0974363955
SYMBOL
52U
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Hyloris Pharmaceuticals
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
28.00 Mil.
MARKET CAPITALISATION
126.00 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
2.74 %
0.22 %
-15.73 %
-39.68 %
-32.23 %
-59.09 %
-67.03 %
-18.18 %
HIGH4.704.705.488.108.1013.3518.608.10
LOW4.324.204.204.204.203.283.284.20

Dividende

pro Aktie
Hyloris Pharmaceuticals does not deliver dividend information

Company profile

Hyloris Pharmaceuticals SA engages in the provision of development and reformulating of pharmaceutical products. It offers commercial-stage products, Sotalol IV for the treatment of atrial fibrillation, and Maxigesic IV, a novel, dual modeof-action non-opioid analgesic for the treatment of post-operative pain. The company was founded by Stijn van Rompay and Thomas Jacobsen in 2012 and is headquartered in Liege, Belgium.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.